Alpha DNA Investment Management’s Rithm Capital RITM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37,188
Closed -$403K 145
2024
Q4
$403K Buy
37,188
+2,484
+7% +$26.9K 0.15% 172
2024
Q3
$394K Buy
34,704
+4,186
+14% +$47.6K 0.15% 182
2024
Q2
$333K Buy
+30,518
New +$338K 0.13% 186

Other funds holding RITM

Alpha DNA Investment Management's RITM Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Rithm Capital (RITM) in Q1 2025, closing a stake of 37,188 shares — an estimated $403K sold.

Alpha DNA Investment Management first reported a position in RITM in Q2 2024 and held it in 3 quarters. The position peaked at $403K in Q4 2024. 501 funds tracked by Wall St. Rank hold RITM as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Rithm Capital position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 37,188 Rithm Capital shares in Q1 2025, an estimated $403K.
  • Alpha DNA Investment Management first reported a position in Rithm Capital in Q2 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's Rithm Capital position peaked at $403K in Q4 2024.
  • 501 funds tracked by Wall St. Rank held Rithm Capital as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.